Chargement en cours...
Repurposing drugs to target nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD) is a complex disorder that has evolved in recent years as the leading global cause of chronic liver damage. The main obstacle to better disease management pertains to the lack of approved pharmacological interventions for the treatment of nonalcoholic steatoh...
Enregistré dans:
| Publié dans: | World J Gastroenterol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478618/ https://ncbi.nlm.nih.gov/pubmed/31057294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i15.1783 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|